Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix by Steve Jones and Martin Lane January 31, 2024July 11, 2024 Avecho Biotechnology will begin its low-dose CBD phase III clinical trial in the next two months […]
AusCann set to import product from Germany under Eurocann tie-up by Steve Jones July 26, 2023April 30, 2024
Former AusCann CEO joins MGC Pharma as non-executive director by Steve Jones June 5, 2023April 30, 2024
AusCann remains in holding pattern as proposed acquisition is delayed by Steve Jones May 1, 2023April 30, 2024
Company news: Cann Global; Elixinol; Bod Science; AusCann; IvyMed Clinic; Botanix by Steve Jones and Martin Lane April 5, 2023April 30, 2024
AusCann offloads 52% of CannPal to founder Layton Mills in move to ‘unlock potential’ of animal business by Steve Jones March 13, 2023April 30, 2024
Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023April 30, 2024
AusCann boss Layton Mills looks for love in season 10 of Married At First Sight by Martin Lane February 13, 2023April 30, 2024
